Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Caveolin 3 Antikörper:
anti-Mouse (Murine) Caveolin 3 Antikörper:
anti-Rat (Rattus) Caveolin 3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Mouse (Murine) Monoclonal Caveolin 3 Primary Antibody für IF, IP - ABIN967959
Lavitrano, Bacci, Forni, Lazzereschi, Di Stefano, Fioretti, Giancotti, Marfé, Pucci, Renzi, Wang, Stoppacciaro, Stassi, Sargiacomo, Sinibaldi, Turchi, Giovannoni, Della Casa, Seren, Rossi: Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 5 Pubmed References
Mouse (Murine) Monoclonal Caveolin 3 Primary Antibody für IF, IP - ABIN967960
Woodman, Park, Cohen, Cheung, Chandra, Shirani, Tang, Jelicks, Kitsis, Christ, Factor, Tanowitz, Lisanti: Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. in The Journal of biological chemistry 2002
Show all 5 Pubmed References
Human Polyclonal Caveolin 3 Primary Antibody für FACS, ICC - ABIN258384
Dınız, Eryaşar, Türe, Akçay, Ortaç, Tekgül, Akhan: A regional panorama of dysferlinopathies. in Turk patoloji dergisi 2012
Human Polyclonal Caveolin 3 Primary Antibody für IHC (p), IHC - ABIN451754
Fine, Lisanti, Argani, Li: Caveolin-3 is a sensitive and specific marker for rhabdomyosarcoma. in Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2005
Case series demonstrates that exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations and broadens phenotypic spectrum of caveolinopathies. Percussion-induced rapid muscle contractions were seen in 5 of 6 patients. A previously reported heterozygous mutation in CAV3 (p.T78M) and 3 novel variants (p.V14I, p.F41S, p.F54V) were identified. >50% reduction of caveolin-3 in 5 patients vs controls.
our study indicates that TASK-1 (zeige KCNK3 Antikörper) is functionally regulated by caveolin-3, possibly via association with each other on the cell surface. These results point out a novel mechanism in the regulation of TASK-1 (zeige KCNK3 Antikörper).
The caveolin 3 G56S variant is not a clearly pathogenic mutation, but may influence cellular functions and morphologies resulting in an increased cellular vulnerability in terms of a modifying factor.
Our results indicate that HCN4 (zeige HCN4 Antikörper) channel function is modulated by cav-3. LQTS-associated mutations of cav-3 differentially influence pacemaker current properties indicating a pathophysiological role in clinical manifestations.
This study demonstrated that the Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis.
Study characterized the secondary structure, dynamics, and topology of a lipidated full-length human Cav3 construct, demonstrated that the N-terminal domain undergoes a dramatic topological rearrangement in both micelles and vesicles that is reversibly mediated by pH
The Cav3 P104L mutation of limb girdle muscular dystrophy-1C leads to disordered glucose metabolism in muscle cells.
Data (including data from studies using recombinant proteins that lack typical in-vivo post-translational modifications such as palmitoylation) suggest Cav3 exhibits little tendency to partition into liquid-ordered domains of unilamellar vesicles.
MURC/cavin-4 (zeige MURC Antikörper), especially in combination with Cav-3, may play a consistent role in the differentiation process of rhabdomyosarcoma.
This study demonstrated that cav3 mutation in stinct disorders including limb-girdle muscular dystrophy 1C, rippling muscle disease, and isolated creatine kinase elevation in Greece.
CAV3 protein has a physiological role in glycometabolism, growth and proliferation, independent of insulin (zeige INS Antikörper) stimulation
Data show that caveolin-3 binds to low glycosylated extracellular matrix metalloproteinase inducer (LG-EMMPRIN) in cardiac cells and in the hearts of healthy mice.
Cav-3 overexpressing mice have changes in ECG intervals, heart rates, and cardiac ion channel expression
Loss of CAV3 interferes with downstream insulin (zeige INS Antikörper) signaling and lipid uptake and increases susceptibility to palmitate-induced insulin (zeige INS Antikörper) resistance.
eNOS (zeige NOS3 Antikörper), caveolin-3, and connexin-43 (zeige GJA1 Antikörper) were detected in subsarcolemmal mitochondria
Data show increased expression of T-type Ca(2 (zeige CA2 Antikörper)+) current and association of protein kinase C alpha (PKCalpha (zeige PKCa Antikörper)) with caveolin-3 (Cav-3)was disrupted in the hypertrophic ventricular myocyte.
Cardioprotection in myocardial infarction is abolished in caveolin-3 knockout mice.
The lithogenic diet was associated with significantly lower CAV3 in the liver and lower CAV3 and CCKAR (zeige CCKAR Antikörper) in the gallbladder compared with the control mice.
Cav-3 may be a novel participant in B-cell expression, T-cell cytokine production and activation of inflammation
Cav3 is involved in muscle development and is required for correct intracellular organization and myoblast fusion.
cloned and characterized caveolin-3 from porcine muscle; caveolin-3 was expressed specifically in skeletal muscle & heart; first evidence that caveolin-3 has a certain regulated expression pattern during the prenatal period of skeletal muscle development
This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.
, calveolin 3
, caveolin 3